Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the ron receptor

Autor: Lorenza Penengo, Marta Minetto, Sara Orecchia, Giovanni Gaudino, Michele Cilli, Massimo Santoro
Přispěvatelé: University of Zurich, Gaudino, G
Rok vydání: 1998
Předmět:
Cancer Research
Lung Neoplasms
Mice
Nude

610 Medicine & health
Receptors
Cell Surface

Tropomyosin receptor kinase C
Receptor tyrosine kinase
Mice
1311 Genetics
Proto-Oncogene Proteins
1312 Molecular Biology
Genetics
Animals
Drosophila Proteins
Humans
Point Mutation
1306 Cancer Research
Neoplasm Metastasis
Phosphorylation
Molecular Biology
Mitogen-Activated Protein Kinase 1
biology
10061 Institute of Molecular Cancer Research
Proto-Oncogene Proteins c-ret
JNK Mitogen-Activated Protein Kinases
MST1R
Receptor Protein-Tyrosine Kinases
3T3 Cells
Oncogenes
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-kit
Cell Transformation
Neoplastic

Phenotype
COS Cells
Calcium-Calmodulin-Dependent Protein Kinases
ROR1
biology.protein
Cancer research
570 Life sciences
Sarcoma
Experimental

Mitogen-Activated Protein Kinases
Protein Kinases
Tyrosine kinase
HeLa Cells
Signal Transduction
Proto-oncogene tyrosine-protein kinase Src
Zdroj: Scopus-Elsevier
ISSN: 1476-5594
0950-9232
DOI: 10.1038/sj.onc.1201994
Popis: Ron (the receptor for Macrophage Stimulating Protein) has never been implicated before in human malignancies or in cell transformation. In this report we show that Ron can acquire oncogenic potential by means of two amino acid substitutions-D1232V and M1254T-affecting highly conserved residues in the tyrosine kinase domain. The same mutations in Kit and Ret have been found associated with two human malignancies, mastocytosis and Multiple Endocrine Neoplasia type 2B (MEN2B), respectively. Both mutations caused Ron-mediated transformation of 3T3 fibroblasts and tumour formation in nude mice. Moreover, cells transformed by the oncogenic Ron mutants displayed high metastatic potential. The Ron mutant receptors were constitutively active and the catalytic efficiency of the mutated kinase was higher than that of wild-type Ron. Oncogenic Ron mutants enhanced activation of the Ras/MAPK cascade with respect to wild type Ron, without affecting the JNK/SAPK pathway. Expression of Ron mutants in 3T3 fibroblasts led to different patterns of tyrosine-phos-phorylated proteins. These data show that point mutations altering catalytic properties and possibly substrate specificity of the Ron kinase may force cells toward tumorigenesis and metastasis.
Databáze: OpenAIRE